John McArdle, M.D.

Assistant Professor

Dr. McArdle is the Co Investigator of the industry sponsored study evaluating the effects of Infliximab in Sarcoidosis.

Training

Medical school: State University of New York at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY
Residency: Yale-New Haven Hospital, New Haven, CT
Fellowship: Yale University School of Medicine

Clinical interests

Critical Care, Pulmonary arterial hypertension, Lung cancer, cystic fibrosis, sarcoidosis

Research and scholarly interest

pharmacologic management of chronic pulmonary sarcoidosis, medical education, acute lung injury

Representative publications

Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q, Ma B, Du Y, Roux F, McArdle J, Waxman AB, Elias JA. IL-13 stimulates vascular endotheliai growth factor and protects against hyperoxic acute lung injury. Journal of Clinical Investigation 2000; 106:783-791

McArdle JR. The role of PET scan for the diagnosis, staging and post treatment surveillance of non-small cell lung cancer. Pulmonary and Critical Care Update 2004, in press.

Contact

Campus Address
Department of Internal Medicine
P.O. Box 208057
New Haven, CT 06520-8057

E-mail
john.mcardle@yale.edu

Phone
203-785-6359

Fax
203-785-3634

Appointments
203-785-4198